Study Highlights Factors Associated With Risk for Diarrhea Bug
By Denise Mann
WebMD Health News
Latest Infectious Disease News
Reviewed by Laura J. Martin, MD
Nov. 2, 2011 -- About 500,000 people in the U.S. become infected with the potentially fatal diarrhea bug Clostridium difficile (C. diff.) each year. Now a new study sheds light on who is most at risk -- and why.
Some people show evidence of C. diff in their gut but never have any symptoms. Others develop a range of symptoms from mild diarrhea to severe diarrhea, abdominal pain, bleeding, and fever. C. diff is typically seen in the health care setting, such as hospitals.
In the study of 4,143 people who were hospitalized, 2.8% were infected with C. diff and 3% had evidence of the bacteria, but no symptoms (colonization).
The study shows that people who test positive for the NAP1 strain of C. diff are most likely to suffer the symptoms. People who don't develop symptoms likely have evidence of other strains of this bug. What's more, the use of antibiotics, acid-suppressing proton pump inhibitors (PPIs), and older age all increase the risk of C. diff infection.
"The findings add to the understanding of Clostridium difficile infection and colonization and have implications for prevention and therapy," conclude researchers who were led by Vivian G. Loo, MD, of McGill University Health Center in Montreal.
Antibiotics and Anti-Reflux Drugs
Antibiotics can wipe out bacteria, which can offset the balance between good and bad bacteria in the gut, setting the stage for C. diff infection.
PPIs such as Nexium, Prevacid, Prilosec, and Protonix may increase this risk in a different way. Stomach acid is one of the main defenses against bacteria. These drugs suppress acid, which may give bacteria the freedom to run rampant in your gut.
"We know the micro-organisms in the gut is a delicate balance of good and bad bacteria, which can be disrupted by many things," Robynne Chutkan, MD, says in an email. She is an assistant professor of medicine at Georgetown University Hospital in Washington, D.C. and founder and medical director at Digestive Center for Women in Chevy Chase, Md.
This includes the inappropriate or overuse of antibiotics, as well as changing the acidity level of the gastrointestinal tract with acid suppression. "We need to be more judicious with our prescribing patterns of these drugs," she says.
Anthony A. Starpoli, MD, agrees. He is the associate director of advanced esophageal endotherapy at Lenox Hill Hospital in New York City.
"A single dose of antibiotics increases your risk of C. diff by upsetting the flora," he says. "We have people calling their doctor and saying, 'I have a cold and a runny nose and need an antibiotic.' This is a big problem."
Antibiotics are not effective in treating a common cold caused by a virus. They are effective against bacterial infections.
Starpoli affirms that PPI overuse may also be partly to blame. "These are perhaps the most prescribed drugs in the world, and we have patients who get them, but don't need them." They are commonly recommended for treating gastroesophageal reflux disease (GERD), and some peptic ulcers,
Along with prescription doses, PPIs are also sold over the counter, meaning people can self-medicate.
"Someone who has a little reflux once or twice a month should not be on a PPI," he tells WebMD.
"We need to decide if a patient really requires long-term use of PPIs and think about drug holidays in those that do, as well as alternatives to manage the symptoms," Starpoli says.
"It is amazing for the frequency with which we see C. diff infection in the hospital and how little we know about the natural history of this infection and this study provides a lot of insight into the process," says Brian Currie, MD, MPH. He is an infectious disease physician at Montefiore Medical Center in the Bronx, N.Y.
The findings may pave the way toward new treatments, he says.
The new findings do not change the fact that C. diff is serious, Starpoli says. "If you have fever, diarrhea, abdominal pain, and bleeding and have been exposed to antibiotics, are taking a PPI and/or have recently been hospitalized or around someone who has, call your doctor."
SOURCES: Anthony A. Starpoli, MD, associate director of advanced esophageal endotherapy, Lenox Hill Hospital, New York City.Robynne Chutkan, MD, assistant professor of medicine, Georgetown University Hospital, Washington, D.C.; medical director, Digestive Center for Women, Chevy Chase, Md.Loo, V.G. New England Journal of Medicine, 2011.Brian Currie, MD, MPH, infectious disease physician, Montefiore Medical Center, Bronx, N.Y.
©2011 WebMD, LLC. All Rights Reserved.